Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Market Cap	2.41B -16.7%
Revenue (ttm)	569.77M -6.8%
Net Income	53.51M -36.4%
EPS	1.19 -36.2%
Shares Out	45.38M
PE Ratio	44.78
Forward PE	n/a
Dividend	1.05 (1.98%)
Ex-Dividend Date	Jun 26, 2025

Volume	60,940
Average Volume	54,404
Open	53.90
Previous Close	54.50
Day's Range	53.10 - 54.90
52-Week Range	50.60 - 80.40
Beta	-0.06
RSI	42.06
Earnings Date	May 14, 2026

About TPEX:4747

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 172
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4747

Financial Performance

In 2025, TPEX:4747's revenue was 569.77 million, a decrease of -6.81% compared to the previous year's 611.42 million. Earnings were 53.51 million, a decrease of -36.40%.